alexa Immunological And Virological Discordance In Patients On Antiretroviral Therapy: Still A Grey Area In HIV Research
ISSN: 2161-0517

Virology & Mycology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

10th World Congress on Virology and Mycology
May 11-12, 2017 Singapore

Ganesh Shanmugasundaram Anusuya
Sree Balaji Medical College and Hospital, India
ScientificTracks Abstracts: Virol-mycol
DOI: 10.4172/2161-0517-C1-020
Abstract
Statement of the Problem: Effective ART generally results in immune reconstitution with increased CD4 and virologic suppression with undetectable HIV viral load (VL). However a major concern regarding ART is when there is a discordant response between CD4 count and the viral load. There are two types of discordant responses: Immunological failure (decrease in CD4 count) despite VL suppression or immune reconstitution (increase in CD4 count) despite VL failure. Interestingly both types of discordant responses to ART are related to AIDS defining events and mortality. Discussion: The discordant response to ART is still a grey area in HIV research. Several studies done around the world have shown the prevalence of discordance ranging from 8% to more than 20%. Several causes attributed for discordant response were Zidovudine based regimen, protease inhibitors, older age, younger median age, lower baseline CD4 count, associated opportunistic infections and baseline viral loads. The wide differences in prevalence of discordance can be attributed to several factors including different criteria for immunological response, virologic suppression, sample size, variation in time to failure, ethnic background and importantly different types of ART regimens. We also recommend the global HIV related authorities to implement uniform guidelines for immunological and virological response, so that the wide difference attributed to the prevalence of discordance can be assessed and decided whether it is a true difference in prevalence. These discordant groups need to be carefully monitored for opportunistic infections and more studies are needed as to ways to improve the immunologic response in these patients and also to find out the exact cause of discordance. Further studies like exploring the genetic sequencing of this discordant group is required.
Biography

Ganesh Shanmugasundaram Anusuya has been working in the field of HIV/AIDS since 2006 in India. He has worked as Tamil Nadu State AIDS Control (TANSACS) STI Medical Officer, ART Medical Officer and HIV Community Care Centre Medical Officer. After Undergraduation, he completed his fellowship in HIV Medicine from Government Hospital of Thoracic Medicine (GHTM), Tambaram, which is a Centre of Excellence for HIV treatment, care and support in India. He has been selected as best outgoing fellow and worked as Chief Fellow in International Training and Education Centre for Health, India. Subsequently, he completed his MD in Community Medicine from Sree Balaji Medical College and Hospital (SBMCH), Bharath University, Chennai. He was the first person as Principal Investigator to study about discordant response to ART in patients enrolled in a Government programme in India. He has done international presentations of his research work in Africa, UK, India, France, and in USA with many publications. He has been nominated by GHTM and SBMCH for the SAARC Prize on HIV/AIDS 2016 pertaining to his contributions in HIV research. His areas of research interest are discordant response to ART, virology, Quality of Life, clinical immunology and public health. Currently he is involved in HIV research, undergraduate & postgraduate teaching, in-charge of free medical camp activities, guiding PhD candidates, conducting conferences, CME, and Public health awareness programmes in SBMCH as an Assistant Professor in Community Medicine department.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version